|
TVIS44042826
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
21048165 |
21048165 |
p11.23 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042827
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
17505885 |
17505885 |
p12.1 |
BFSP1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042828
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
17505839 |
17505839 |
p12.1 |
BFSP1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042829
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
14067008 |
14067008 |
p12.1 |
MACROD2 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042830
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
13511691 |
13511691 |
p12.1 |
TASP1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042831
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
13511637 |
13511637 |
p12.1 |
TASP1 |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042832
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
12433684 |
12433684 |
p12.1 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042833
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
12433683 |
12433683 |
p12.1 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042834
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
12433679 |
12433679 |
p12.1 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |
|
TVIS44042835
|
Human T-lymphotropic Virus |
- |
- |
- |
- |
hg38 |
chr20 |
11884678 |
11884678 |
p12.2 |
- |
Tumor |
Asymptomatic carrier |
High throughput sequenicng |
35654946 |
2022 |
Curated |